|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Investments at fair value | ||||||||||||||
| Non- affiliated investments | ||||||||||||||
| Controlled/affiliated investments | ||||||||||||||
| Total investments at fair value | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Foreign currency, at value (cost $1,417 and $197, respectively) | ||||||||||||||
| Cash | ||||||||||||||
| Cash equivalents (cost of 4,157) | ||||||||||||||
| Foreign currency, at value (cost of $275 and $2,132, respectively) | ||||||||||||||
| Interest receivable from non-controlled/non-affiliated investments | ||||||||||||||
| Dividends receivable from non-controlled/non-affiliated investments | ||||||||||||||
| Deferred financing costs | ||||||||||||||
| Receivable for investments sold | ||||||||||||||
| Unrealized appreciation on OTC forward foreign currency exchange contracts | ||||||||||||||
| Deposit for Investments Purchased | ||||||||||||||
| Due from Manager | ||||||||||||||
| Other assets | ||||||||||||||
| Prepaid expenses | ||||||||||||||
| Total assets | ||||||||||||||
| LIABILITIES | ||||||||||||||
| Debt | ||||||||||||||
| Payable for investments purchased | ||||||||||||||
| Incentive fees payable | ||||||||||||||
| Capital gains incentive fee payable | ||||||||||||||
| Management fees payable | ||||||||||||||
| Distribution payable (Note 8) | ||||||||||||||
| Payable for reverse repurchase agreements (cost of $0 and $7,670, respectively) | ||||||||||||||
| Unrealized depreciation on OTC forward foreign currency exchange contracts | ||||||||||||||
| Professional fees payable | ||||||||||||||
| Accrued financing cost payable | ||||||||||||||
| Pricing fees payable | ||||||||||||||
| Interest payable | ||||||||||||||
| Blue sky fees payable | ||||||||||||||
| Accrued pricing fees payable | ||||||||||||||
| Custodian and accounting fees payable | ||||||||||||||
| Promissory notes payable | ||||||||||||||
| Transfer agent's fees payable | ||||||||||||||
| Related Party | ||||||||||||||
| Total transfer agent's fees payable | ||||||||||||||
| Affiliated transfer agent's fees payable | ||||||||||||||
| Trustees' fees payable | ||||||||||||||
| Service and distribution fees payable | ||||||||||||||
| Accrued expense and other liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| NET ASSETS | ||||||||||||||
| Common Shares, $0.001 par value (unlimited shares authorized; 11,893,415 and 8,230,021 shares issued and outstanding, respectively) | ||||||||||||||
| Paid in capital in excess of par | ||||||||||||||
| Total distributable earnings/(accumulated losses) | ||||||||||||||
| Class I Shares | ||||||||||||||
| Class S Shares | ||||||||||||||
| Class D Shares | ||||||||||||||
| Total net assets | ||||||||||||||
| Common shares outstanding ($0.001 par value, unlimited shares authorized) | ||||||||||||||
| Class I Shares | ||||||||||||||
| Class S Shares | ||||||||||||||
| Class D Shares | ||||||||||||||
| Total common shares outstanding ($0.001 par value, unlimited shares authorized) | ||||||||||||||
| Net asset value, offering price and redemption price per share | ||||||||||||||
| Class I Shares | ||||||||||||||
| Class S Shares | ||||||||||||||
| Class D Shares | ||||||||||||||
| Total liabilities and net assets | ||||||||||||||
Loading...